China (Mainland)
Assessedsupplier
- Product Details
Keywords
- 2-(tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid
- Manufacturer (audit and TDP support)
- Lifitegrast
Quick Details
- ProName: Lifitegrast intermediate
- CasNo: 851784-82-2
- Molecular Formula: C4H11NOS
- Appearance: White to Off-White solid
- Application: Lifitegrast intermediate
- DeliveryTime: within 4 weeks
- PackAge: standard package
- Port: TBC
- ProductionCapacity: commercial production Metric Ton/Day
- Purity: 99%
- Storage: room temperature
- Transportation: Non-hazardous
- LimitNum: 1 Kilogram
- Moisture Content: ≤0.5%
- Impurity: ≤0.5%
Superiority
Commercial production in Northwest plant.
Commercial production from grams to tons, with technical documents package support, and audit and inspection support.
With high purity and optimized and stable process.
Details
MW: 346.21
Senova means Self Innovation
SENOVA PHARMA is committed to the development and production of API’s and advanced intermediates. We develop every intermediate process from the first step to API.
We insist on product development and production technology platform combining chemical synthesis (drug synthesis) technology, enzyme synthesis (biocatalytic and biotransformation) technology and microbial fermentation (biosynthesis) technology.
Our own production base and our cooperative plants in China produce products according to cGMP application, providing customers with stable and reliable whole-chain solutions， esp in anti-tumor and anti-cancer fields.